Biologic treatment planning for high-dose-rate brachytherapy

Area of Science:

• Radiation Oncology
• Medical Physics
• Radiobiology

Background:

• Conventional interstitial brachytherapy planning optimizes for total dose and homogeneity.
• This approach overlooks the biologic impact of varying dose rates inherent in HDR treatments.
• Dose rate changes during HDR implant treatment due to source movement can affect cell kill.

Purpose of the Study:

• To apply radiobiologic principles to assess the biologic effects of varying dose rates in HDR brachytherapy.
• To compare biologic effect homogeneity with dose homogeneity in HDR implants.
• To investigate the influence of dose rate sequencing on cell survival.

Main Methods:

• Utilized a generalized linear-quadratic (LQ) model to calculate cell surviving fractions under HDR irradiation.
• Compared surviving fractions at points receiving the same total dose but different HDR irradiation profiles.
• Analyzed effects using varying LQ parameters (alpha, beta, T(1)) and irradiation times.

Main Results:

• Cell surviving fractions varied significantly (up to an order of magnitude) even in regions of uniform dose.
• These variations were more pronounced with shorter repair times, smaller alpha/beta ratios, and longer total irradiation times.
• Dose homogeneity does not guarantee biologic effect homogeneity in HDR brachytherapy.

Conclusions:

• HDR treatment planning based solely on dose distribution may not accurately reflect clinical outcomes.
• Biologic effect modeling, considering irradiation history and repair kinetics, can enhance HDR brachytherapy planning.
• This approach may improve prediction of adverse effects like fat necrosis and fibrosis.